New depression drug DT-101 enters Mid-Stage trial
Symptom relief
Recruiting now
This study tests a new medicine called DT-101 for adults with major depression. About 300 people will receive either DT-101 or a placebo. Researchers will check if depression symptoms improve after 6 weeks using standard questionnaires.
Phase: PHASE2 • Sponsor: Draig Therapeutics Ltd • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC